PARIS, November 10, 2023--Regulatory News: On 10 November 2023, the liquidity contract between BNP Paribas Arbitrage and Carmila (Paris:CARM) dated 28 June 2019 was terminated. On 3 November 2023, Carmila and Kepler Cheuvreux signed a liquidity contract concerning the liquidity of Carmila shares (ISIN : FR0010828137), (the Shares) admitted for trading on Euronext Paris (the Contract), which will begin on 13 November 2023.
PARIS, November 09, 2023--Regulatory News: CARMILA (Paris:CARM):
Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today reported financial results for the quarter ended September 30, 2023, and highlighted recent business updates.